Labcorp Completes Millennium Health Acquisition to Expand Toxicology Testing
The deal adds a specialty laboratory focused on drug testing and surveillance to Labcorp's national network.
Category: Company News
Company News
Latest
Company News
Latest
Labcorp to Acquire Select BioReference Health Assets for $722M
Labcorp will acquire select BioReference Health assets from OPKO Health for $722 million, including clinical, urology, and women’s health labs, 80+ patient service centers, and the FDA-approved 4Kscore prostate cancer test.
Company News
Latest
Leica Biosystems Acquires StatLab Medical Products
Leica Biosystems has acquired StatLab Medical Products, expanding its anatomic pathology portfolio with pre-analytical consumables and equipment to support clinical histology workflows.
Helix Launches Whole Exome Sequencing Test Combining Exome, Mitochondrial, and Digital Karyotype Analysis
Helix has introduced Whole Exome+ Sequencing, a single-order assay that combines exome, mitochondrial, and digital karyotype analysis, with 99% coverage of clinically relevant regions.
Read More
Quest Diagnostics to Integrate 50-Biomarker Test Panel into Apple Health App
Quest Diagnostics will integrate a 50-biomarker lab test panel into the Apple Health app, allowing US users to order preventive testing and access clinical results on iPhone and iPad.
Read More
PixCell Medical Expands HemoScreen Hematology Analyzer into Canada
PixCell Medical has received Health Canada Class III licensing for its HemoScreen point-of-care hematology analyzer and signed a Canadian distribution agreement with Inter Medico, expanding access to decentralized CBC testing.
Read More
Labcorp Acquires MLM Medical Labs to Expand Clinical Trial Laboratory Network
Labcorp has acquired MLM Medical Labs, expanding its central laboratory network to four continents and strengthening biomarker and specialty testing capabilities for clinical trials, according to a company announcement.
Read More
Watchmaker Genomics Expands Boulder Campus to More Than Double Manufacturing Capacity
Watchmaker Genomics will more than double its manufacturing capacity by leasing a 100,000-square-foot facility in Boulder, Colo, to support increased demand for genomics and molecular diagnostics reagents.
Read More
Thermo Fisher Launches Microplate Reader for Routine Absorbance Assays
Thermo Fisher Scientific has introduced the Multiskan Ease Absorbance Microplate Reader, a single-mode system designed to streamline routine assays such as ELISAs and protein quantification for laboratory workflows.
Read More
Humanity and Quest Diagnostics Launch Biological Age Analysis in the US
Humanity Health and Quest Diagnostics have launched a biological age analysis add-on for select health profile tests in the US, allowing users to assess aging biomarkers using routine blood samples.
Read More
Medicare Expands Coverage for NeoGenomics RaDaR ST Assay to Include Immunotherapy Monitoring
Medicare has expanded coverage for NeoGenomics’ RaDaR ST MRD assay to include monitoring immunotherapy response in patients with late-stage solid tumors.
Read More
Court Orders Guardant Health to Pay $245 Million in Patent Infringement Suit
A federal court ordered Guardant Health to pay more than $245 million to TwinStrand Biosciences and the University of Washington in a patent infringement case. Guardant Health is appealing the judgment.
Read More
Seed Healthcare Leads Strategic Investment in Diadem for US Commercialization of Alzheimer’s Diagnostic
Seed Healthcare has led a strategic investment in Diadem to support US commercialization of AlzoSure Predict, a blood-based Alzheimer’s diagnostic recently validated in over 900 patients and designated a Breakthrough Device by the FDA.
Read More
Quest Diagnostics to Launch FDA-Cleared Alzheimer Blood Test and Multi-Biomarker Panel
Quest Diagnostics will launch an FDA-cleared Roche pTau217 Alzheimer’s blood test and a new multi-biomarker LDT, expanding its AD-Detect portfolio for improved diagnostic accuracy in late 2026.
Read More
Labcorp to Offer First FDA-Cleared Blood Test for Alzheimer Disease Pathology
Labcorp will offer the FDA-cleared Elecsys pTau-217 blood test, developed by Roche Diagnostics, to aid in identifying amyloid pathology linked to Alzheimer’s in patients 55 and older with cognitive decline.
Read More
Craif Secures $34 Million to Launch Urine-Based Cancer Test in US Market
Craif Inc has raised $34 million in Series D funding to support a US launch of its urine-based cancer test, expand San Diego lab operations, and advance a pancreatic cancer study and regulatory filing in Japan.
Read More
Labcorp, NACHC Alliance Will Use Laboratory Data to Improve Community Health
The strategic alliance will leverage de-identified laboratory data to support quality improvement across 1,526 community health centers and includes a leadership exchange program for chief medical officers.
Read More
AI Platform Will Extract Clinical Insights from Laboratory and Pathology Data for IBD and MASH Research
Century Health and GI Partners of Illinois have partnered to create a real-world data ecosystem for IBD and MASH, leveraging AI to extract clinical insights from lab data, pathology reports, and imaging to support research and pharmaceutical innovation.
Read More